|
CCDC6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.868000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.750000E-01 |
| Normal-vs-Stage2 |
1.643890E-02 |
| Normal-vs-Stage3 |
3.134100E-02 |
| Normal-vs-Stage4 |
1.881950E-02 |
| Stage1-vs-Stage2 |
1.257760E-02 |
| Stage1-vs-Stage3 |
1.452440E-02 |
| Stage1-vs-Stage4 |
1.029590E-02 |
| Stage2-vs-Stage3 |
6.280800E-01 |
| Stage2-vs-Stage4 |
6.012600E-01 |
| Stage3-vs-Stage4 |
9.727200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.858590E-01 |
| Normal-vs-AfricanAmerican |
6.231500E-04 |
| Normal-vs-Asian |
2.600400E-01 |
| Caucasian-vs-AfricanAmerican |
6.239200E-03 |
| Caucasian-vs-Asian |
2.787600E-01 |
| AfricanAmerican-vs-Asian |
1.806350E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.597400E-01 |
| Normal-vs-Female |
1.202320E-02 |
| Male-vs-Female |
5.662200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.869800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.042000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.707900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.753700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.015200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.985400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.241650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.931400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.674600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.574800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.452800E-01 |
| Normal-vs-Grade 2 |
8.498600E-01 |
| Normal-vs-Grade 3 |
3.313500E-02 |
| Normal-vs-Grade 4 |
1.980980E-04 |
| Grade 1-vs-Grade 2 |
7.204400E-01 |
| Grade 1-vs-Grade 3 |
1.712770E-01 |
| Grade 1-vs-Grade 4 |
7.407600E-02 |
| Grade 2-vs-Grade 3 |
1.921850E-02 |
| Grade 2-vs-Grade 4 |
8.13420000000953E-05 |
| Grade 3-vs-Grade 4 |
4.434400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.415800E-01 |
| Normal-vs-ccB subtype |
2.695400E-01 |
| ccA subtype-vs-ccB subtype |
3.154800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.579360E-01 |
| Normal-vs-N1 |
3.741000E-01 |
| N0-vs-N1 |
9.572000E-01 |
|
|
